You can find the annual or quarterly income statement of SpyGlass Pharma Ord shs (Proposed) here for insights into the performance and operational efficiency of SpyGlass Pharma Ord shs (Proposed).

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2026Q1

Operating expenses

--15.41M

R&D expenses

--8.54M

Depreciation, depletion, and amortization

--318.00K

Operating profit

---15.41M

Net non-operating interest income (expenses)

Non-operating interest income

--1.59M

Special income (expenses)

--0.00

Income before tax

---13.82M

Income tax

--0.00

Income after tax

---13.82M

Net income from continuous operations

---13.82M

Net income attributable to controlling interests

---13.82M

Net income attributable to common shareholders

---13.82M

Basic earnings per share

---0.69

Diluted earnings per share

---0.69

Currency unit

USD

Audit opinions

FAQs

What is the income statement?



The income statement, also known as the profit and loss statement, shows the revenues, expenses, profits, and losses of the company over a specific accounting period.

KeyAI

